The private equity and investment groups Nordic Capital and Permira, are poised to take over Bavarian Nordic A/S of Denmark in order to help the company scale up its vaccine work globally. An offer of DKK 19 billion ($2.95 billion) was published on 28 July and accepted by the company’s management subject to the approval of shareholders. Bavarian Nordic is listed on Nasdaq Copenhagen and also has an American Depository Share (ADS) programme allowing US investors to trade the shares locally.
